Enviar noticia por correo electronico
Remitente:
Nombre:
Email:
Destinatario:
Nombre:
Email:
World's First Recombinant Botulinum Toxin Type A New Drug Received Marketing Approval in China: a Technological Revolution pioneered by Claruvis Pharmaceutical
PR News |
28 abr, 2026 14:38